explore -WSS

explore

author：comprehensive 2025-09-03 05:38:39 - browse：16

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： STAT Summit: GSK CEO on pharma giant's new direction

focus

WSS

Researchers explore possible ties between long Covid, menopause

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Trump team launching legal defense fund to help pay legal bills

The explosion of genetic testing requires a new approach

Will Ozempic

American TikTok star stuck in Dubai for months following rental car altercation

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Continuity nursing helped my family in our darkest PICU moments

Doctors increasingly discourage vaping amid mounting health concerns

Activists slam private health insurers over coverage restrictions

NIH confirmation hearing shows politicization of research

Cancer drug shortages should be causing more outrage

Solve the antibiotic resistance crisis with preventive drugs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Doctors in states that ban abortion can still help patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lawmakers consider Medicare pay reforms for doctors

entertainment

Pharmacists can make shortage drugs, but at what cost?

Medicare reduced heart disease by changing how it pays doctors

The explosion of genetic testing requires a new approach

The explosion of genetic testing requires a new approach

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

House GOP plan to stem drug shortages differs from Democrats’

focus

hotspot

focus

explore